Abstract

Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding

Author(s): Hyde Tiffany D

Issue: Jan/Feb 2014 - Volume 18, Number 1

Page(s): 46-52

Download in electronic PDF format for $75
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 1
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 2
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 3
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 4
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 5
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 6
  • Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Page 7

Abstract

The purpose of this article is to describe United States Pharmacopeia Chapter <71> Sterility Tests from the perspective of Current Good Manufacturing Practices in order to aid compounding pharmacists in understanding the details and complexities that are required. Compounding pharmacists face a unique challenge in the industry today, with their compounding practice and the U.S. Food and Drug Administration trying to impose Current Good Manufacturing Practices guidelines. Naturally, this becomes a challenge to contract testing laboratories as well, as they are caught between the testing for non-Current Good Manufacturing Practices compounding standards and Current Good Manufacturing Practices manufacturing. It is important that the compounding pharmacist and their partner testing laboratory work closely together to ensure appropriate requirements are being met.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2007
Pg. 400-403
Author(s): Kupiec Thomas C
Mar/Apr 2021
Pg. 115-124
Author(s): Kelley Brian
Nov/Dec 2021
Pg. 491-496
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 46-52
Author(s): Hyde Tiffany D
Mar/Apr 2020
Pg. 92
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 213-221
Jan/Feb 2006
Pg. 36-39
Author(s): Dawson Michael F
Mar/Apr 2012
Pg. 146-150
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 299-303
Author(s): Taylor Andrew
Mar/Apr 2014
Pg. 123-130
May/Jun 2017
Pg. 193-203
Author(s): Mixon William, Roth Abby
Jul/Aug 2013
Pg. 307-311
Author(s): McElhiney Linda F
May/Jun 2011
Pg. 224-232
Sep/Oct 2007
Pg. 404-410
Jan/Feb 2005
Pg. 47-49
Author(s): Kupiec Thomas C
Jul/Aug 2010
Pg. 317-320
Author(s): Dawson Michael E
Sep/Oct 2013
Pg. 439
Author(s): Allen Loyd V Jr
Jul/Aug 2007
Pg. 302-305
Author(s): Okeke Claudia C
Mar/Apr 2005
Pg. 136-138
Author(s): Kupiec Thomas C